Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06511596Not ApplicableCompleted

A Prospective Trial of Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AC

Role: lead

NCT06811909Not ApplicableRecruiting

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

Role: lead

NCT06565156Not ApplicableActive Not Recruiting

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

Role: lead

NCT06150209Not ApplicableUnknown

A Controlled Prospective Treatment Study to Evaluate the Efficacy of Vendaje.

Role: lead

All 4 trials loaded